ON-DEMAND WEBINAR
From Asset to Blockbuster: The New Blueprint for Drug Repurposing
Transforming a single indication asset into a market-leading brand is the ultimate goal in pharmaceutical development. This journey is often slowed by disconnected data, uncertain clinical paths, and regulatory hurdles. A new approach now makes it possible to systematically de-risk the entire lifecycle strategy, empowering teams to identify new indications, build a powerful evidence package, and align commercial and regulatory plans before committing millions to new trials. Join our webinar to see the results of a landmark study on the Basil platform. We will unveil a methodology that unites product strategy, translational science, regulatory affairs, and commercial opportunity into a single engine driven by data.
What you will learn:
- How our integrated analysis was 100% accurate in identifying clinically validated label expansions within the top 3 candidates
- The power of triangulation across 60,000 global labels, submissions, clinical studies, pharmacovigilance, and other data points to build a robust narrative
- How this approach provides a 4x improvement over siloed pharmacovigilance analysis (100% vs. 24% accuracy)
- See how the framework’s top candidates were prospectively validated with publicly disclosed research directions in 80% of new cases
Stop navigating your portfolio strategy with incomplete data. Fill in the form to access the full on-demand webinar and learn how to create a systematic engine for asset maximization, regulatory success, and peak commercial value.
Access Full On-Demand Webinar
This webinar is designed for leaders who need to:
- Product & Commercial Strategy: De-risk lifecycle management, accurately validate new market opportunities, and build a business case to secure investment and outperform competitors
- Translational Sciences: Evolve from serendipitous discovery to a reproducible, evidence-based framework for generating therapeutic hypotheses
- Regulatory Strategy: Act as a strategic partner to other teams by providing early, data-fueled assessments of regulatory viability and prioritizing promising label expansion pathways
"It’s amazing. You did that in like 2 seconds. I just spent probably a whole week trying to find and filter through this data. That just saved me weeks worth of scouring data, and it’s even more complete and accurate." Sr. Regulatory Affairs Specialist, Bayer
"The team at Basil Systems is honest and reliable, providing advice and points of view that are grounded in fact." Director, Top Ten Pharma Company
"Wow, this is game changing. Seeing how many things are interconnected and referenced – that’s invaluable data for us to help build our plans and strategies.” VP, Biotech
Webinar Speaker:

Sam Kay
Sam Kay is a strategic Regulatory Affairs leader specializing in all things pharma at Basil Systems. With over 12 years of experience, he has driven global labelling initiatives — from clinical development through commercialization — ensuring that products meet rigorous regulatory standards across key markets. Passionate about leveraging technology to enhance regulatory practices, his innovative approach to labeling and compliance continues to set industry benchmarks and inspire forward-thinking solutions in pharmaceutical product development.
Transform a gamble to science:
Achieve 100% accuracy in predicting drug repurposing success!
Access On-Demand Webinar